Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease. [electronic resource] by
- Zhang, Lu
- Zhao, Ai-Lin
- Duan, Ming-Hui
- Li, Zhi-Yuan
- Cao, Xin-Xin
- Feng, Jun
- Zhou, Dao-Bin
- Zhong, Ding-Rong
- Fajgenbaum, David C
- Li, Jian
Producer: 20191223
In:
Blood vol. 133
Availability: No items available.
|
|
|
19.
|
Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease. [electronic resource] by
- Pierson, Sheila K
- Stonestrom, Aaron J
- Shilling, Dustin
- Ruth, Jason
- Nabel, Christopher S
- Singh, Amrit
- Ren, Yue
- Stone, Katie
- Li, Hongzhe
- van Rhee, Frits
- Fajgenbaum, David C
Producer: 20190710
In:
American journal of hematology vol. 93
Availability: No items available.
|
|
|
20.
|
Idiopathic multicentric Castleman's disease: a systematic literature review. [electronic resource] by
- Liu, Amy Y
- Nabel, Christopher S
- Finkelman, Brian S
- Ruth, Jason R
- Kurzrock, Razelle
- van Rhee, Frits
- Krymskaya, Vera P
- Kelleher, Dermot
- Rubenstein, Arthur H
- Fajgenbaum, David C
Producer: 20171018
In:
The Lancet. Haematology vol. 3
Availability: No items available.
|